Kirk Tanner

Kirk Tanner

Company: National Brain Tumor Society

Job title: CSO and SVP Brain Tumor Investment Fund


Panel Discussion: Unifying the Voice & the Impact of Stakeholders to Accelerate LBx Application, Approval & Reimbursement Path Across the Continuum of Patient Care 3:30 pm

Inspiring a discussion to unite stakeholders on the collaborations needed to identifying a robust and accelerated path to make liquid biopsy application, approval and reimbursement a reality across the continuum of patient care Understanding what does the future hold for liquid biopsy and where change and innovation need to come from to make meaningful directional…Read more

day: Day Two PM

Leveraging the Utilization of Liquid Biopsy in CNS Tumors to Measure Circulating Tumor Biomarkers 2:30 pm

Summarising the landscape of liquid biopsy in CNS tumors Highlighting the challenges and opportunities of integrating liquid biopsy in brain tumors due to the blood-brain barrier Elevating the use of liquid biopsy for monitoring tumor progression and response to therapiesRead more

day: Day One Track A PM

Paving the Path Towards Standardized Pre- Analytical Approaches in Liquid Biopsy
11:15 am

Read more

day: Day Two Track A AM

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.